Ad
related to: bristol-myers stock
Search results
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
WROC Rochester· 7 days ago(NASDAQ: ONCY) (TSX: ONC), TScan Therapeutics, Inc. (NASDAQ: TCRX), Bristol-Myers Squibb Company...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoNeuroscience drugs, including potential Alzheimer’s and schizophrenia, could yield billions in annual sales for the company if approved by regulators,...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters via Yahoo News· 2 days agoThe study of 423 patients with stage 3 melanoma found that 83.7% of patients who received the...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters· 2 days ago, opens new tab immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer...
Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options' - Boston...
The Business Journals· 6 days agoFor the second time this year, Ikena Oncology is once again cutting its workforce and slimming down...
Salesforce is the most oversold stock on Wall Street amid a losing week for the markets
CNBC· 3 days agoThe S & P 500 and the Nasdaq Composite are both on pace to snap five-week winning streaks, while the...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters via Yahoo News· 5 days ago(Reuters) -Bristol Myers Squibb said on Thursday the U.S. FDA had allowed expanded use of its cell...
A 'robust' earnings outlook is driving further optimism for stocks in 2024
AOL· 6 days agoS&P 500 (^GSPC) earnings grew 6% in the first quarter from a year ago, according to data from FactSet. When excluding dismal earnings from Bristol Myers-Squibb (BMY), the ...
Pipeline for Acquisition Financing Shrinks, in Boon for Credit
Bloomberg via Yahoo News· 7 days ago...Companies have fewer acquisitions to refinance in longer-term debt markets now than they did a...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 5 days ago, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for an...
